Clovis Oncology Stock Forecast NASDAQ:CLVS

Price Target and Analyst Ratings

Most Recent Rating

On August 05, 2021 "HC Wainwright" gave "$12.00 - $10.00" rating for CLVS. The price target was changed from $4.82 to 0.8%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-05	$12.00 - $10.00	Target Lowered by	HC Wainwright	$5.06	$4.82→0.8%
2021-05-11	Buy	Target Lowered by	HC Wainwright	$5.61	$13.00 → $12.00
2021-05-05	Buy	Target Lowered by	HC Wainwright	$5.86	$13.00 → $12.00
2021-02-23	Buy	Target Lowered by	HC Wainwright	$6.01	$15.00 → $13.00
2021-01-14	Buy	Reiterated by	HC Wainwright	$5.96	$15.00
2021-01-08	Buy	Reiterated by	HC Wainwright	$5.05
2020-11-06	Buy	Target Lowered by	HC Wainwright	$4.26	$23.00 → $15.00
2020-11-06	Underperform	Target Lowered by	SVB Leerink	$4.26	$4.00 → $3.00
2020-11-05	Neutral	Target Lowered by	Piper Sandler	$4.47	$6.00 → $5.00
2020-11-01	Hold	Reiterated by	JPMorgan Chase & Co.	$4.93
2020-09-21	Buy	Reiterated by	HC Wainwright	$7.07	$23.00
2020-09-03	Buy	Reiterated by	HC Wainwright	$5.08
2020-08-06	Buy	Reiterated by	HC Wainwright	$6.23
2020-05-20	Underperform	Target Lowered by	SVB Leerink	$7.50	$5.00 → $4.00
2020-05-18	Buy	Target Raised by	HC Wainwright	$8.96	$29.00 → $33.00
2020-05-06	Neutral	Target Raised by	Piper Sandler	$8.07	$5.25 → $6.00
2020-05-06	Buy	Target Raised by	HC Wainwright	$8.07	$27.00 → $29.00
2020-04-27	Market Perform - Underperform	Downgraded by	SVB Leerink	$8.17	$5.00
2020-04-20	Buy	Reiterated by	Royal Bank of Canada	$9.40	$17.00
2020-04-19	Neutral - Underperform	Downgraded by	Bank of America	$8.16
2020-04-15	Buy	Reiterated by	HC Wainwright	$7.21	$27.00
2020-04-09	Neutral - Underperform	Downgraded by	Bank of America	$6.70	$6.00

CLVS Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -25.57% during the next 3 months and, with a 90% probability hold a price between $2.64 and $3.71 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$3.52	$4.24	$4.96
2021-09-21	$3.49	$4.21	$4.93
2021-09-22	$3.46	$4.18	$4.91
2021-09-23	$3.43	$4.16	$4.88
2021-09-24	$3.41	$4.13	$4.85
2021-09-27	$3.38	$4.10	$4.83
2021-09-28	$3.35	$4.08	$4.80
2021-09-29	$3.33	$4.05	$4.77
2021-09-30	$3.30	$4.02	$4.74
2021-10-01	$3.27	$3.99	$4.72
2021-10-04	$3.24	$3.97	$4.69
2021-10-05	$3.22	$3.94	$4.66
2021-10-06	$3.19	$3.91	$4.64
2021-10-07	$3.16	$3.88	$4.61
2021-10-08	$3.13	$3.86	$4.58
2021-10-11	$3.11	$3.83	$4.55
2021-10-12	$3.08	$3.80	$4.53
2021-10-13	$3.05	$3.78	$4.50
2021-10-14	$3.03	$3.75	$4.47
2021-10-15	$3.00	$3.72	$4.44
2021-10-18	$2.97	$3.69	$4.42
2021-10-19	$2.94	$3.67	$4.39
2021-10-20	$2.92	$3.64	$4.36
2021-10-21	$2.89	$3.61	$4.34
2021-10-22	$2.86	$3.59	$4.31
2021-10-25	$2.84	$3.56	$4.28
2021-10-26	$2.81	$3.53	$4.25
2021-10-27	$2.78	$3.50	$4.23
2021-10-28	$2.75	$3.48	$4.20
2021-10-29	$2.73	$3.45	$4.17

About Clovis Oncology

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucapar... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!